ELCO Management
UTHR icon

ELCO Management’s United Therapeutics UTHR Stock Holding History

ELCO Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$217K Hold
400
– – 0.1% 151
2026
Q2 		$217K Sell
400
-6
-1% -$3.38K 0.09% 161
2026
Q1 		$241K Buy
+406
New +$202K 0.12% 144
2025
Q1 		– Sell
-669
Closed -$236K – 164
2024
Q4 		$236K Sell
669
-8
-1% -$2.94K 0.12% 139
2024
Q3 		$243K Sell
677
-53
-7% -$17.9K 0.13% 139
2024
Q2 		$233K Sell
730
-181
-20% -$47.9K 0.14% 131
2024
Q1 		$209K Buy
+911
New +$206K 0.13% 138

Other funds holding UTHR

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

ELCO Management's UTHR Position: Q3 2026 in Review

ELCO Management held its United Therapeutics (UTHR) position steady in Q3 2026 at 400 shares worth $217K. The position accounts for 0.1% of the portfolio, ranked #151.

ELCO Management first reported a position in UTHR in Q1 2024 and has held it in 7 quarters since. The position peaked at $243K in Q3 2024. 567 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • ELCO Management held 400 shares of United Therapeutics worth $217K as of Q3 2026.
  • ELCO Management left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up 0.1% of ELCO Management's portfolio in Q3 2026, its #151 holding.
  • ELCO Management first reported a position in United Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • ELCO Management's United Therapeutics position peaked at $243K in Q3 2024.
  • 567 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on ELCO Management's 13F filing for Q3 2026, filed 14 Oct 2026.